<DOC>
	<DOCNO>NCT01671280</DOCNO>
	<brief_summary>To collect efficacy safety information Azithromycin IV related appropriate use daily practice</brief_summary>
	<brief_title>Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pelvic Inflammatory Disease</mesh_term>
	<mesh_term>Pelvic Infection</mesh_term>
	<criteria>Male Female patient prescribe Zithromac IV communityacquired pneumonia pelvic inflammatory disease . Subjects prescribed Zithromac ZithromacSR communityacquired pneumonia pelvic inflammatory disease .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>community-acquired pneumonia</keyword>
	<keyword>pelvic inflammatory disease</keyword>
	<keyword>Zithromax</keyword>
	<keyword>Zithromac</keyword>
	<keyword>Japanese</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan</keyword>
</DOC>